The effect of hepatic cirrhosis on the pharmacokinetics and blood pressure response to nicardipine
β Scribed by Razak, T A; McNeil, J J; Sewell, R B; Drummer, O H; Smallwood, R A; Conway, E L; Louis, W J
- Book ID
- 109844865
- Publisher
- Nature Publishing Group
- Year
- 1990
- Tongue
- English
- Weight
- 572 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0009-9236
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The influence of hepatic disease on the pharmacokinetics of the new ACE inhibitor, benazepril hydrochloride, was evaluated in 12 male patients suffering from liver cirrhosis. The patients received a single oral 20 mg dose. The plasma concentrations and urinary excretion of unchanged benazepril and i
## Physical exercise increases portal pressure (hepatic venous pressure gradient [HVPG]) in patients with cirrhosis. It is unknown if this deleterious effect is associated with changes in gastroesophageal collateral blood flow and if these can be prevented by propranolol administration. The aim of
Both cimetidine therapy and cirrhosis individually interfere with normal elimination of various drugs. Cimetidine is often prescribed in patients with cirrhosis but there is incomplete data on its effect on drug elimination in cirrhotics. The purpose of this study was to address this issue. Eight st